Your browser doesn't support javascript.
Laboratory preparedness for SARS-CoV-2 testing in India: Harnessing a network of Virus Research & Diagnostic Laboratories.
Gupta, Nivedita; Potdar, Varsha; Praharaj, Ira; Giri, Sidhartha; Sapkal, Gajanan; Yadav, Pragya; Choudhary, Manohar Lal; Dar, Lalit; Sugunan, A P; Kaur, Harmanmeet; Munivenkatappa, Ashok; Shastri, Jayanthi; Kaveri, Krishnasamy; Dutta, Shanta; Malhotra, Bharti; Jain, Amita; Nagamani, Kammilli; Shantala, G B; Raut, Sharmila; Vegad, M M; Sharma, Ajanta; Choudhary, Aashish; Brijwal, Megha; Balakrishnan, Anukumar; Manjunatha, Jayaswamy; Pathak, Manish; Srinivasan, Sivasubramanian; Banu, Hasina; Sharma, Himanshu; Jain, Parul; Sunita, Pakalpati; Ambica, R; Fageria, Babita; Patel, Disha; Rajbongshi, Gitika; Vijay, Neetu; Narayan, Jitendra; Aggarwal, Neeraj; Nagar, Anu; Gangakhedkar, Raman R; Abraham, Priya.
  • Gupta N; Division of Epidemiology & Communicable Diseases, Indian Council of Medical Research, New Delhi, India.
  • Potdar V; Influenza Group, ICMR-National Institute of Virology, Pune, India.
  • Praharaj I; Division of Epidemiology & Communicable Diseases, Indian Council of Medical Research, New Delhi, India.
  • Giri S; Division of Epidemiology & Communicable Diseases, Indian Council of Medical Research, New Delhi, India.
  • Sapkal G; Maximum Containment Laboratory, ICMR-National Institute of Virology, Pune, India.
  • Yadav P; Maximum Containment Laboratory, ICMR-National Institute of Virology, Pune, India.
  • Choudhary ML; Influenza Group, ICMR-National Institute of Virology, Pune, India.
  • Dar L; Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
  • Sugunan AP; ICMR-National Institute of Virology Kerala Unit, Alappuzha, Kerala, India.
  • Kaur H; Department of Health Research, Ministry of Health & Family Welfare, Government of India, New Delhi, India.
  • Munivenkatappa A; ICMR-National Institute of Virology Bangalore Field Unit, Bengaluru, Karnataka, India.
  • Shastri J; Department of Microbiology, Kasturba Hospital for Infectious Diseases, Mumbai, India.
  • Kaveri K; Department of Virology, King Institute of Preventive Medicine & Research, Chennai, Tamil Nadu, India.
  • Dutta S; ICMR-National Institute of Cholera & Enteric Diseases, Kolkata, West Bengal, India.
  • Malhotra B; Department of Microbiology, Sawai Man Singh Medical College, Jaipur, Rajasthan, India.
  • Jain A; Department of Microbiology, King George's Medical University, Lucknow, Uttar Pradesh, India.
  • Nagamani K; Department of Microbiology, Gandhi Medical College & Hospital, Secunderabad, Telangana, India.
  • Shantala GB; Bangalore Medical College & Research Institute, Bengaluru, Karnataka, India.
  • Raut S; Department of Microbiology, Indira Gandhi Government Medical College & Hospital, Nagpur, Maharashtra, India.
  • Vegad MM; Department of Microbiology, Byramjee Jeejeebhoy Medical College, Ahmedabad, Gujarat, India.
  • Sharma A; Department of Microbiology, Gauhati Medical College & Hospital, Guwahati, Assam, India.
  • Choudhary A; Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
  • Brijwal M; Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
  • Balakrishnan A; ICMR-National Institute of Virology Kerala Unit, Alappuzha, Kerala, India.
  • Manjunatha J; ICMR-National Institute of Virology Bangalore Field Unit, Bengaluru, Karnataka, India.
  • Pathak M; Department of Microbiology, Kasturba Hospital for Infectious Diseases, Mumbai, India.
  • Srinivasan S; Department of Virology, King Institute of Preventive Medicine & Research, Chennai, Tamil Nadu, India.
  • Banu H; ICMR-National Institute of Cholera & Enteric Diseases, Kolkata, West Bengal, India.
  • Sharma H; Department of Microbiology, Sawai Man Singh Medical College, Jaipur, Rajasthan, India.
  • Jain P; Department of Microbiology, King George's Medical University, Lucknow, Uttar Pradesh, India.
  • Sunita P; Department of Microbiology, Gandhi Medical College & Hospital, Secunderabad, Telangana, India.
  • Ambica R; Bangalore Medical College & Research Institute, Bengaluru, Karnataka, India.
  • Fageria B; Department of Microbiology, Indira Gandhi Government Medical College & Hospital, Nagpur, Maharashtra, India.
  • Patel D; Department of Microbiology, Byramjee Jeejeebhoy Medical College, Ahmedabad, Gujarat, India.
  • Rajbongshi G; Department of Microbiology, Gauhati Medical College & Hospital, Guwahati, Assam, India.
  • Vijay N; Department of Health Research, Ministry of Health & Family Welfare, Government of India, New Delhi, India.
  • Narayan J; Department of Health Research, Ministry of Health & Family Welfare, Government of India, New Delhi, India.
  • Aggarwal N; Division of Epidemiology & Communicable Diseases, Indian Council of Medical Research, New Delhi, India.
  • Nagar A; Department of Health Research, Ministry of Health & Family Welfare, Government of India, New Delhi, India.
  • Gangakhedkar RR; Division of Epidemiology & Communicable Diseases, Indian Council of Medical Research, New Delhi, India.
  • Abraham P; ICMR-National Institute of Virology, Pune, India.
Indian J Med Res ; 151(2 & 3): 216-225, 2020.
Article in English | MEDLINE | ID: covidwho-32576
ABSTRACT
Background &

objectives:

An outbreak of respiratory illness of unknown aetiology was reported from Hubei province of Wuhan, People's Republic of China, in December 2019. The outbreak was attributed to a novel coronavirus (CoV), named as severe acute respiratory syndrome (SARS)-CoV-2 and the disease as COVID-19. Within one month, cases were reported from 25 countries. In view of the novel viral strain with reported high morbidity, establishing early countrywide diagnosis to detect imported cases became critical. Here we describe the role of a countrywide network of VRDLs in early diagnosis of COVID-19.

Methods:

The Indian Council of Medical Research (ICMR)-National Institute of Virology (NIV), Pune, established screening as well as confirmatory assays for SARS-CoV-2. A total of 13 VRDLs were provided with the E gene screening real-time reverse transcription-polymerase chain reaction (rRT-PCR) assay. VRDLs were selected on the basis of their presence near an international airport/seaport and their past performance. The case definition for testing included all individuals with travel history to Wuhan and symptomatic individuals with travel history to other parts of China. This was later expanded to include symptomatic individuals returning from Singapore, Japan, Hong Kong, Thailand and South Korea.

Results:

Within a week of standardization of the test at NIV, all VRDLs could initiate testing for SARS-CoV-2. Till February 29, 2020, a total of 2,913 samples were tested. This included both 654 individuals quarantined in the two camps and others fitting within the case definition. The quarantined individuals were tested twice - at days 0 and 14. All tested negative on both occasions. Only three individuals belonging to different districts in Kerala were found to be positive. Interpretation &

conclusions:

Sudden emergence of SARS-CoV-2 and its potential to cause a pandemic posed an unsurmountable challenge to the public health system of India. However, concerted efforts of various arms of the Government of India resulted in a well-coordinated action at each level. India has successfully demonstrated its ability to establish quick diagnosis of SARS-CoV-2 at NIV, Pune, and the testing VRDLs.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Mass Screening / Coronavirus Infections / Clinical Laboratory Techniques Type of study: Diagnostic study / Etiology study / Observational study / Prognostic study Topics: Vaccines Limits: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Country/Region as subject: Asia Language: English Journal: Indian J Med Res Year: 2020 Document Type: Article Affiliation country: Ijmr.IJMR_594_20

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Mass Screening / Coronavirus Infections / Clinical Laboratory Techniques Type of study: Diagnostic study / Etiology study / Observational study / Prognostic study Topics: Vaccines Limits: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Country/Region as subject: Asia Language: English Journal: Indian J Med Res Year: 2020 Document Type: Article Affiliation country: Ijmr.IJMR_594_20